Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

A partial volume effect correction tailored for 18F-FDG-PET oncological studies.

Gallivanone F, Canevari C, Gianolli L, Salvatore C, Della Rosa PA, Gilardi MC, Castiglioni I.

Biomed Res Int. 2013;2013:780458. doi: 10.1155/2013/780458. Epub 2013 Sep 19.

2.

Metabolic impact of partial volume correction of [18F]FDG PET-CT oncological studies on the assessment of tumor response to treatment.

Stefano A, Gallivanone F, Messa C, Gilardi MC, Gastiglioni I.

Q J Nucl Med Mol Imaging. 2014 Dec;58(4):413-23.

PMID:
24732680
3.

18F-FDG-PET partial volume effect correction using a modified recovery coefficient approach based on functional volume and local contrast: physical validation and clinical feasibility in oncology.

Anouan KJ, Lelandais B, Edet-Sanson A, Ruan S, Vera P, Gardin I, Hapdey S.

Q J Nucl Med Mol Imaging. 2017 Sep;61(3):301-313. doi: 10.23736/S1824-4785.17.02756-X. Epub 2015 Sep 25.

4.

Comparative assessment of methods for estimating tumor volume and standardized uptake value in (18)F-FDG PET.

Tylski P, Stute S, Grotus N, Doyeux K, Hapdey S, Gardin I, Vanderlinden B, Buvat I.

J Nucl Med. 2010 Feb;51(2):268-76. doi: 10.2967/jnumed.109.066241. Epub 2010 Jan 15.

5.

Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases?

Parvizi N, Franklin JM, McGowan DR, Teoh EJ, Bradley KM, Gleeson FV.

Eur J Radiol. 2015 Oct;84(10):1873-8. doi: 10.1016/j.ejrad.2015.06.025. Epub 2015 Jun 29.

PMID:
26163992
6.

Defining a radiotherapy target with positron emission tomography.

Black QC, Grills IS, Kestin LL, Wong CY, Wong JW, Martinez AA, Yan D.

Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1272-82.

PMID:
15519800
7.

18F, 11C and 68Ga in small animal PET imaging. Evaluation of partial volume correction methods.

Muellauer J, Willimayer R, Goertzen AL, Wanek T, Langer O, Birkfellner W, Kuntner C.

Nuklearmedizin. 2013 Dec 13;52(6):250-61. doi: 10.3413/Nukmed-0578-13-04.

PMID:
24337014
8.

Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data.

Teo BK, Seo Y, Bacharach SL, Carrasquillo JA, Libutti SK, Shukla H, Hasegawa BH, Hawkins RA, Franc BL.

J Nucl Med. 2007 May;48(5):802-10.

9.

SUV correction for injection errors in FDG-PET examination.

Miyashita K, Takahashi N, Oka T, Asakawa S, Lee J, Shizukuishi K, Inoue T.

Ann Nucl Med. 2007 Dec;21(10):607-13. Epub 2007 Dec 25.

PMID:
18092139
10.

Recovery coefficients determination for partial volume effect correction in oncological PET/CT images considering the effect of activity outside the field of view.

Krempser AR, Ichinose RM, Miranda de Sá AM, Velasques de Oliveira SM, Carneiro MP.

Ann Nucl Med. 2013 Dec;27(10):924-30. doi: 10.1007/s12149-013-0773-x. Epub 2013 Oct 11.

PMID:
24114312
11.

Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status.

Kikuchi M, Koyasu S, Shinohara S, Usami Y, Imai Y, Hino M, Itoh K, Tona R, Kanazawa Y, Kishimoto I, Harada H, Naito Y.

Head Neck. 2015 Oct;37(10):1524-31. doi: 10.1002/hed.23784. Epub 2014 Jul 21.

PMID:
24890445
12.

Does Delayed-Time-Point Imaging Improve 18F-FDG-PET in Patients With MALT Lymphoma?: Observations in a Series of 13 Patients.

Mayerhoefer ME, Giraudo C, Senn D, Hartenbach M, Weber M, Rausch I, Kiesewetter B, Herold CJ, Hacker M, Pones M, Simonitsch-Klupp I, Müllauer L, Dolak W, Lukas J, Raderer M.

Clin Nucl Med. 2016 Feb;41(2):101-5. doi: 10.1097/RLU.0000000000001005.

13.

Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.

Fleisher KE, Raad RA, Rakheja R, Gupta V, Chan KC, Friedman KP, Mourtzikos KA, Janal M, Glickman RS.

J Oral Maxillofac Surg. 2014 Oct;72(10):1957-65. doi: 10.1016/j.joms.2014.04.017. Epub 2014 Apr 24.

PMID:
25053572
14.

Determination of accuracy and precision of lesion uptake measurements in human subjects with time-of-flight PET.

Daube-Witherspoon ME, Surti S, Perkins AE, Karp JS.

J Nucl Med. 2014 Apr;55(4):602-7. doi: 10.2967/jnumed.113.127035. Epub 2014 Mar 6.

15.

F-18-FDG positron imaging in oncological patients: gamma camera coincidence detection versus dedicated PET.

Zimny M, Kaiser HJ, Cremerius U, Sabri O, Schreckenberger M, Reinartz P, Büll U.

Nuklearmedizin. 1999;38(4):108-14.

PMID:
10392375
16.

Impact of partial-volume effect correction on the predictive and prognostic value of baseline 18F-FDG PET images in esophageal cancer.

Hatt M, Le Pogam A, Visvikis D, Pradier O, Cheze Le Rest C.

J Nucl Med. 2012 Jan;53(1):12-20. doi: 10.2967/jnumed.111.092775.

17.
18.

Lesion quantification in oncological positron emission tomography: a maximum likelihood partial volume correction strategy.

De Bernardi E, Faggiano E, Zito F, Gerundini P, Baselli G.

Med Phys. 2009 Jul;36(7):3040-9.

PMID:
19673203
19.

Static and moving phantom studies for radiation treatment planning in a positron emission tomography and computed tomography (PET/CT) system.

Okubo M, Nishimura Y, Nakamatsu K, Okumura M, Shibata T, Kanamori S, Hanaoka K, Hosono M.

Ann Nucl Med. 2008 Aug;22(7):579-86. doi: 10.1007/s12149-008-0166-8. Epub 2008 Aug 29.

PMID:
18756360
20.

Increased metabolic activity in abdominal aortic aneurysm detected by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT).

Kotze CW, Menezes LJ, Endozo R, Groves AM, Ell PJ, Yusuf SW.

Eur J Vasc Endovasc Surg. 2009 Jul;38(1):93-9. doi: 10.1016/j.ejvs.2008.12.016. Epub 2009 Feb 12.

Supplemental Content

Support Center